DNAH10 inhibitors constitute a distinct class of chemical compounds engineered to exert inhibitory effects on the protein DNAH10, a vital member of the dynein superfamily. Dyneins, microtubule-associated molecular motors, play a pivotal role in intracellular transport, particularly in the movement of cilia and flagella. These motile structures are essential for a wide range of physiological processes, including cellular motility, sensory perception, and the clearance of mucus in the respiratory tract. The mechanism underlying DNAH10 inhibitors involves the specific targeting of DNAH10's functional domains or binding sites. Through precise molecular interactions, these inhibitors disrupt the normal binding interactions between DNAH10 and its associated cargo, leading to compromised dynein motor function. This, in turn, can result in impaired ciliary and flagellar movement, which are crucial for processes such as cellular migration, fluid movement, and sensory reception. The inhibition of DNAH10 could potentially lead to a cascade of effects on cellular dynamics and tissue-level functions.
Although the mechanistic details of DNAH10 inhibition are well-defined, it's important to underscore that the broader implications of targeting DNAH10 are complex and multifaceted. While the inhibition of DNAH10 holds promise for elucidating the intricate roles of dyneins in various biological contexts, the comprehensive effects on cellular physiology and organismal biology are subjects that require comprehensive exploration. The utilization of DNAH10 inhibitors as tools for scientific investigation is an area of active research, with ongoing studies aimed at unraveling the intricacies of dynein-driven processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacitidine is a nucleoside analog that gets incorporated into DNA during replication, leading to DNMT binding and subsequent covalent trapping, ultimately inhibiting DNA methylation. This results in hypomethylation and altered gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a cytosine analog that gets incorporated into DNA, causing covalent trapping of DNMT and blocking DNA methylation, leading to gene expression changes. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a small molecule inhibitor that directly binds to the catalytic site of DNMT, blocking its enzymatic activity and preventing DNA methylation. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
SGI-1027 inhibits DNMT by interfering with its binding to DNA, leading to decreased DNA methylation and gene expression changes. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine is a cytidine analog that incorporates into DNA and acts as a competitive inhibitor of DNMT, disrupting DNA methylation patterns. | ||||||